Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [353]

Glioblastoma heterogeneity in circulating tumour DNA

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Glioblastoma heterogeneity in circulating tumour DNA ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief

Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )

Subset of anaplastic glioma patients benefit from adjuvant chemo

Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands

Subset of anaplastic glioma patients benefit from adjuvant chemo ( Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO

ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )

Elderly patients with glioblastoma live longer with chemoradiation using...

Prof James Perry - University of Toronto, Toronto, Canada

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide ( Prof James Perry - University of Toronto, Toronto, Canada )

Elderly patients with glioblastoma live longer with chemoradiation using...

Prof James Perry - University of Toronto, Toronto, Canada

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide ( Prof James Perry - University of Toronto, Toronto, Canada )

Temozolomide after radiotherapy improves glioma survival

Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands

Temozolomide after radiotherapy improves glioma survival ( Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )

Paediatric and adult high grade gliomas: A tale of a histone tail

Dr Nada Jabado - McGill University, Montreal, Canada

Paediatric and adult high grade gliomas: A tale of a histone tail ( Dr Nada Jabado - McGill University, Montreal, Canada )

Understanding personalised medicine - the e-learning course

Prof Gordon McVie

Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )

Cell of origin role in cancer stem cell and GBM phenotype

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA

Cell of origin role in cancer stem cell and GBM phenotype ( Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA )

Retroviral replicating vectors for cancer-targeted gene therapy and...

Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA

Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy ( Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA )

Combination of viroimmunotherapy with checkpoint inhibitors

Prof Alan Melcher - The Institute of Cancer Research and The Royal Marsden...

Combination of viroimmunotherapy with checkpoint inhibitors ( Prof Alan Melcher - The Institute of Cancer Research and The Royal Marsden Hospital, London, UK )

More from ecancer